Bupa (The British United Provident Association Limited), the international health insurer and provider, today announces that it has successfully launched and priced EUR 500 million 5.00 per cent. fixed rate notes due 12 October 2030 (the “Senior Notes”) to be issued by its subsidiary, Bupa Finance plc. The Senior Notes are guaranteed by Bupa.
The Senior Notes are expected to be rated A3 and BBB+ by Moody's and Fitch respectively.
The Senior Notes were priced at a spread over euro mid swaps of 160 basis points and have a maturity date of 12 October 2030.
For further information, please contact:
Investors
Investor Relations: [email protected]
Media
External Relations: [email protected]
DISCLAIMER
This announcement is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Senior Notes or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.
The Senior Notes will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or any U.S. state securities laws, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Senior Notes will be only offered and sold to non-U.S. persons in offshore transactions outside the United States in accordance with Regulation S under the Securities Act.
Stabilisation in respect of the Senior Notes may be conducted in accordance with FCA and International Capital Market Association Rules.
About Bupa
Bupa's purpose is helping people live longer, healthier and happier lives and making a better world. We are an international healthcare company serving over 43 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 82,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong, SAR, Türkiye, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
For more information, visit bupa.com
